Designed for AI-era attacks, Exposure Management helps organizations reduce risk faster using existing security controlsREDWOOD CITY, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Check Point Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global leader in cyber security solutions, today announced Check Point Exposure Management, a new approach designed to help organizations defend against AI-era attacks by turning fragmented exposure data into prioritized, actionable, and safe remediation. Powered by ...

Partnership brings compliant institutional grade market infrastructure to support a secondary market for GLDYLOS ANGELES and NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex”) (NASDAQ: STEX), and tZERO Group, Inc. (“tZERO”), leading innovators in blockchain-powered tokenization infrastructure, are joining forces to support secondary trading of GLDY, a soon-to-be-launched, gold-linked tokenized security, on tZERO’s SEC- and FINRA-regulated alternative trading system (ATS). The collaborat ...

Management Anticipates Significant Growth in Lowes Channel During 2026 Driven by Strong Demand, SKYX Expects Additional Winter Launches with Other Leading U.S. Retailers and Big-Box Chains Management Expects its Ceiling SKYFAN & Turbo Heater to Generate Significant Revenue During this Winter and throughout Fiscal Year 2026 The Company Anticipates that the Turbo Heater Launch Will Advance its Path to Cash-Flow Positive The Ceiling Fan and Space Heater Categories Represent a Multi-Billion-Dollar Annual Market ...

Tel Aviv, Israel, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, recently announced a key breakthrough from its quantum-focused initiatives. Quantum Transportation Ltd. - a minority-owned subsidiary of Quantum X Labs Ltd., the Israeli quantum tech group Viewbix is in the process of acquiring - has successfully completed Milestone 1 in its Transformer-Based Quantum Decoder program. What was achieved in Milestone 1? A thorough pate ...

RA'ANANA, Israel, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN,IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today provided an update highlighting significant progress in the execution of its previously announced binding purchase orders. The Company has received a formal notification from its distribution partner that the $22.5 million and $27 million binding purchase orders, originally announced on July 2, 202 ...

Highlights vertically integrated waste-to-value platform and 2026 operational milestones HOUSTON, TX, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Abundia Global Impact Group, Inc. (NYSE American: AGIG) (“Abundia” or the “Company”), a low-carbon energy solutions company focused on converting biomass and plastics waste into high-value low-carbon fuels, announces it has published an updated investor presentation, which provides a deep dive into Abundia’s core competencies. The Company is focused on delivering a differen ...

-Initiation of phase 1 portion of the trial planned in 2H 2026 -Phase 2 portion of the trial will initiate development of the elraglusib tablet in specific indications, including refractory melanoma and additional target solid tumor and hematologic cancers -Program builds on early clinical evidence of monotherapy activity observed in immune checkpoint inhibitor (CPI)-refractory metastatic melanoma in a previously completed trial CHICAGO and FORT WORTH, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Actuate Therap ...

Autonomous Security Platforms and Award-Winning SARA Take the Spotlight in Las Vegas Detroit, Michigan, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions, along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today confirmed plans to exhibit and present at ISC West, taking place March 23 to 27, 2026 at The Venetian Expo in Las Vegas. RAD will showcase it ...

Core Insights - Beam Global announced the sale of ten EV ARC™ off-grid electric vehicle charging systems at a new residential development in New York, marking its largest sale of such systems into a residential setting to date [1][2] Group 1: Sales and Market Demand - The sale reflects strong customer diversification achieved during 2025, with increasing demand from commercial customers beyond the federal government [1] - The EV ARC™ systems provide on-site EV charging without the need for construction, trenching, electrical upgrades, or utility coordination, addressing challenges in deploying conventional EV charging in dense urban environments [2][4] - The systems generate and store their own renewable electricity, allowing for rapid deployment and minimal disruption to existing site designs [2][3] Group 2: Strategic Growth Opportunities - Historically, Beam Global's customer base has been primarily federal, state, and municipal agencies, but there is now growing interest from residential and commercial developers [4] - The U.S. market presents significant growth opportunities, particularly in the tens of millions of apartments and condominiums that have not been aggressively targeted by Beam Global [4] - Research indicates that national property values could increase by approximately $77.3 billion if all vehicles in the U.S. were electric, highlighting the economic benefits of EV adoption in residential settings [4]

Core Viewpoint - Ocugen, Inc. has announced the pricing of an underwritten offering of 15 million shares of common stock at $1.50 per share, aiming for gross proceeds of $22.5 million, expected to close around January 22, 2026 [1]. Group 1: Offering Details - The offering consists of 15,000,000 shares priced at $1.50 each, resulting in gross proceeds of $22.5 million before expenses [1]. - The offering is led by RTW Investments, with participation from both new and existing investors [1]. - Oppenheimer & Co. is the sole book-running manager for the offering [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general corporate purposes, capital expenditures, working capital, and general and administrative expenses [2]. Group 3: Company Overview - Ocugen, Inc. is a biotechnology leader focused on gene therapies for blindness diseases, with a modifier gene therapy platform aimed at addressing significant unmet medical needs [5]. - The company is developing programs for inherited retinal diseases and blindness diseases, including retinitis pigmentosa, Stargardt disease, and geographic atrophy [5].